Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024)

Historic Interest & Investment Income for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2024 value amounting to $279000.0.

  • Sensus Healthcare's Interest & Investment Income rose 72.2% to $279000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $979000.0, marking a year-over-year decrease of 210.0%. This contributed to the annual value of $382000.0 for FY2022, which is 1900000.0% up from last year.
  • Per Sensus Healthcare's latest filing, its Interest & Investment Income stood at $279000.0 for Q3 2024, which was up 72.2% from $209000.0 recorded in Q2 2024.
  • Over the past 5 years, Sensus Healthcare's Interest & Investment Income peaked at $279000.0 during Q3 2024, and registered a low of $1000.0 during Q4 2021.
  • Over the past 5 years, Sensus Healthcare's median Interest & Investment Income value was $164000.0 (recorded in 2022), while the average stood at $136714.3.
  • Per our database at Business Quant, Sensus Healthcare's Interest & Investment Income crashed by 9732.39% in 2020 and then surged by 2420000.0% in 2023.
  • Over the past 5 years, Sensus Healthcare's Interest & Investment Income (Quarter) stood at $2000.0 in 2020, then tumbled by 50.0% to $1000.0 in 2021, then surged by 23400.0% to $235000.0 in 2022, then increased by 17.87% to $277000.0 in 2023, then rose by 0.72% to $279000.0 in 2024.
  • Its last three reported values are $279000.0 in Q3 2024, $209000.0 for Q2 2024, and $214000.0 during Q1 2024.